TUCSON, Ariz. , Feb. 21, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial results for the quarter and year ended December 31, 2018 after the market close…
TUCSON, Ariz. , Feb. 21, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cowen & Company 39th…
TUCSON, Ariz. , Feb. 20, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its second precision diagnostic partnership program (“PDP Two”) with QIAGEN Manchester Limited…
TUCSON, Ariz. , Feb. 20, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the 8 th Annual SVB Leerink…
TUCSON, Ariz. , Jan. 23, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has appointed Dr. Joseph Sparano as lead of its Breast Cancer Program Scientific Advisory Board (SAB)….
HTG EdgeSeq Reveal is a new software product to analyze HTG EdgeSeq Precision Immuno‑Oncology Panel data TUCSON, Ariz. , Jan. 16, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced…
Chief Executive Officer TJ Johnson to assume role of Executive Chairman at the end of first quarter 2019 John Lubniewski , President and Chief Operating Officer, appointed as successor TUCSON, Ariz. , Jan. 14, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
TUCSON, Jan. 07, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced preliminary, unaudited financial results for the full year ended December 31, 2018 ….
TUCSON, Ariz. , Dec. 18, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the formation of a French subsidiary, HTG Molecular Diagnostics France SARL (“HTG France”) in November 2018…
GÖTEBORG, Sweden and TUSCON, Ariz., Dec. 05, 2018 (GLOBE NEWSWIRE) – TATAA Biocenter, Europe’s leading provider of genomic services, and HTG Molecular Diagnostics, Inc (HTG) (Nasdaq: HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the…
TUCSON, Ariz. , Nov. 12, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview the Canaccord…
Revenue increased 26% and 101% for the three and nine months ended September 30, 2018 compared to the respective prior year periods Call scheduled for today, November 8 , at 4:30 pm ET TUCSON, Ariz. , Nov. 08, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc….
Page last updated March 20, 2023